RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Carl Zeiss Meditec Stock

Carl Zeiss Meditec Liabilities 2024

Carl Zeiss Meditec Liabilities

873.47 M EUR

Ticker

AFX.DE

ISIN

DE0005313704

WKN

531370

In 2024, Carl Zeiss Meditec's total liabilities amounted to 873.47 M EUR, a 8.14% difference from the 807.72 M EUR total liabilities in the previous year.

Carl Zeiss Meditec Aktienanalyse

What does Carl Zeiss Meditec do?

Carl Zeiss Meditec AG is a globally leading provider of medical technologies and devices for diagnostics and therapy. The company's history dates back to the founding of Carl Zeiss in 1846 in Jena, Germany. It has a long tradition in the development and manufacture of optical devices, particularly microscopes and binoculars. In 1996, Carl Zeiss decided to spin off its medical technology business segment and establish Carl Zeiss Meditec AG. Since then, the company has developed a wide portfolio of products used in ophthalmology and other medical fields. The business model of Carl Zeiss Meditec is based on three pillars: devices for diagnostics and therapy, software, and services. The devices are offered in various divisions specialized in specific application areas. The ophthalmology division is the largest and most well-known area of the company. It offers a wide range of diagnostic and therapy devices used in the treatment of eye diseases such as glaucoma, cataract, and retinal disorders. The products of the ophthalmology division include OCT systems (optical coherence tomography) for detailed examination of the retina, as well as VisuMax laser technology for correction of vision defects. Another important area of Carl Zeiss Meditec is the neurosurgery division. It offers devices for stereotactic neurosurgery used in the treatment of brain tumors, movement disorders, and other neurological conditions. The products of this division include the Kinevo stereotactic navigation system and the OPMI Neuro/NC4 surgical microscope series. In the dental division, Carl Zeiss Meditec provides innovative solutions for dentistry. This includes optical impression systems (Artemis), CAD/CAM systems, and dental microscopes. In addition to products, Carl Zeiss Meditec also offers software solutions for medical imaging and data processing. The FORUM software platform allows for intuitive management of medical images and findings. The company also provides training and education for doctors and medical professionals. The products of Carl Zeiss Meditec are known for their high quality, reliability, and precision. The company focuses on innovative technologies and continuously invests in research and development to strengthen its position as a market leader in the medical technology industry. Carl Zeiss Meditec is present in more than 60 countries worldwide and employs around 3,000 people. It is headquartered in Jena, Germany, and has additional locations in the United States, Canada, China, India, and other countries. Overall, Carl Zeiss Meditec AG is an innovative and reliable partner for the medical technology industry. Its wide range of products and services contributes to improving the health of millions of people worldwide. Carl Zeiss Meditec ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Carl Zeiss Meditec's Liabilities

Carl Zeiss Meditec's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Carl Zeiss Meditec's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Carl Zeiss Meditec's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Carl Zeiss Meditec's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Carl Zeiss Meditec’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Carl Zeiss Meditec stock

What is the level of liabilities of Carl Zeiss Meditec this year?

Carl Zeiss Meditec has a debt balance of 873.47 M EUR this year.

What were the liabilities of Carl Zeiss Meditec compared to the previous year?

The liabilities of Carl Zeiss Meditec have increased by 8.14% increased compared to the previous year.

What are the consequences of high debt for investors of Carl Zeiss Meditec?

High liabilities can pose a risk for investors of Carl Zeiss Meditec, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Carl Zeiss Meditec?

Low liabilities mean that Carl Zeiss Meditec has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Carl Zeiss Meditec affect the company?

An increase in liabilities of Carl Zeiss Meditec can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Carl Zeiss Meditec affect the company?

A decrease in the liabilities of Carl Zeiss Meditec can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Carl Zeiss Meditec?

Some factors that can influence the liabilities of Carl Zeiss Meditec include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Carl Zeiss Meditec so important for investors?

The liabilities of Carl Zeiss Meditec are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Carl Zeiss Meditec take to modify the liabilities?

To change its liabilities, Carl Zeiss Meditec can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Carl Zeiss Meditec pay?

Over the past 12 months, Carl Zeiss Meditec paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Carl Zeiss Meditec is expected to pay a dividend of 1.22 EUR.

What is the dividend yield of Carl Zeiss Meditec?

The current dividend yield of Carl Zeiss Meditec is .

When does Carl Zeiss Meditec pay dividends?

Carl Zeiss Meditec pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Carl Zeiss Meditec?

Carl Zeiss Meditec paid dividends every year for the past 20 years.

What is the dividend of Carl Zeiss Meditec?

For the upcoming 12 months, dividends amounting to 1.22 EUR are expected. This corresponds to a dividend yield of 2.54 %.

In which sector is Carl Zeiss Meditec located?

Carl Zeiss Meditec is assigned to the 'Health' sector.

Wann musste ich die Aktien von Carl Zeiss Meditec kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Carl Zeiss Meditec from 3/26/2024 amounting to 1.1 EUR, you needed to have the stock in your portfolio before the ex-date on 3/22/2024.

When did Carl Zeiss Meditec pay the last dividend?

The last dividend was paid out on 3/26/2024.

What was the dividend of Carl Zeiss Meditec in the year 2023?

In the year 2023, Carl Zeiss Meditec distributed 0.9 EUR as dividends.

In which currency does Carl Zeiss Meditec pay out the dividend?

The dividends of Carl Zeiss Meditec are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Carl Zeiss Meditec stock can be added to a savings plan with the following providers: Trade Republic and Consorsbank

Andere Kennzahlen von Carl Zeiss Meditec

Our stock analysis for Carl Zeiss Meditec Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Carl Zeiss Meditec Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.